MICROPORT CARDIO.MEDTECH. (72X) - Net Assets
Based on the latest financial reports, MICROPORT CARDIO.MEDTECH. (72X) has net assets worth €2.22 Billion EUR (≈ $2.59 Billion USD) as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€2.67 Billion ≈ $3.12 Billion USD) and total liabilities (€450.55 Million ≈ $526.74 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check MICROPORT CARDIO.MEDTECH. (72X) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €2.22 Billion |
| % of Total Assets | 83.11% |
| Annual Growth Rate | -10.47% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 4.26 |
MICROPORT CARDIO.MEDTECH. - Net Assets Trend (2021–2024)
This chart illustrates how MICROPORT CARDIO.MEDTECH.'s net assets have evolved over time, based on quarterly financial data. Also explore balance sheet size of MICROPORT CARDIO.MEDTECH. for the complete picture of this company's asset base.
Annual Net Assets for MICROPORT CARDIO.MEDTECH. (2021–2024)
The table below shows the annual net assets of MICROPORT CARDIO.MEDTECH. from 2021 to 2024. For live valuation and market cap data, see 72X stock market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | €2.22 Billion ≈ $2.60 Billion |
-4.85% |
| 2023-12-31 | €2.33 Billion ≈ $2.73 Billion |
-15.21% |
| 2022-12-31 | €2.75 Billion ≈ $3.22 Billion |
-11.07% |
| 2021-12-31 | €3.10 Billion ≈ $3.62 Billion |
-- |
Equity Component Analysis
This analysis shows how different components contribute to MICROPORT CARDIO.MEDTECH.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 96986600000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | €3.98 Billion | 182.05% |
| Total Equity | €2.19 Billion | 100.00% |
MICROPORT CARDIO.MEDTECH. Competitors by Market Cap
The table below lists competitors of MICROPORT CARDIO.MEDTECH. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Indo Rama Synthetics (India) Limited
NSE:INDORAMA
|
$107.59 Million |
|
Definitive Healthcare Corp
NASDAQ:DH
|
$107.61 Million |
|
Odlewnie Polskie SA
WAR:ODL
|
$107.65 Million |
|
Shemen Industries Ltd
TA:SMNIN
|
$107.67 Million |
|
Celxpert Energy
TWO:3323
|
$107.56 Million |
|
Biotalys NV
BR:BTLS
|
$107.45 Million |
|
Gray Television Inc
NYSE:GTN-A
|
$107.44 Million |
|
Dyaco International Inc
TW:1598
|
$107.42 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in MICROPORT CARDIO.MEDTECH.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 2,334,863,000 to 2,187,212,000, a change of -147,651,000 (-6.3%).
- Net loss of 49,446,000 reduced equity.
- Share repurchases of 39,124,000 reduced equity.
- New share issuances of 129,000 increased equity.
- Other factors decreased equity by 59,210,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €-49.45 Million | -2.26% |
| Share Repurchases | €39.12 Million | -1.79% |
| Share Issuances | €129.00K | +0.01% |
| Other Changes | €-59.21 Million | -2.71% |
| Total Change | €- | -6.32% |
Book Value vs Market Value Analysis
This analysis compares MICROPORT CARDIO.MEDTECH.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.27x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2021-12-31 | €1.29 | €0.25 | x |
| 2022-12-31 | €1.14 | €0.25 | x |
| 2023-12-31 | €0.99 | €0.25 | x |
| 2024-12-31 | €0.92 | €0.25 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently MICROPORT CARDIO.MEDTECH. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -2.26%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -13.68%
- • Asset Turnover: 0.14x
- • Equity Multiplier: 1.22x
- Recent ROE (-2.26%) is above the historical average (-11.22%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2021 | -5.92% | -91.26% | 0.06x | 1.09x | €-492.91 Million |
| 2022 | -16.50% | -181.02% | 0.08x | 1.09x | €-729.77 Million |
| 2023 | -20.20% | -140.25% | 0.13x | 1.10x | €-705.02 Million |
| 2024 | -2.26% | -13.68% | 0.14x | 1.22x | €-268.17 Million |
Industry Comparison
This section compares MICROPORT CARDIO.MEDTECH.'s net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $791,853,474
- Average return on equity (ROE) among peers: -26.05%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| MICROPORT CARDIO.MEDTECH. (72X) | €2.22 Billion | -5.92% | 0.20x | $107.57 Million |
| HeraMED Limited (1I4) | $2.59 Million | -168.10% | 0.60x | $26.40 Million |
| Medtronic PLC (2M6) | $841.50 Million | 23.43% | 0.53x | $101.71 Billion |
| Peijia Medical Limited (4WO) | $2.04 Billion | -11.08% | 0.32x | $403.65 Million |
| AVITA Medical Inc (51KB) | $20.86 Million | -118.03% | 0.23x | $172.49 Million |
| MODULIGHT OY EO 1 (78W) | $44.68 Million | -10.30% | 0.10x | $43.97 Million |
| ACOTEC SCIEN.H. DL-00001 (7W3) | $1.28 Billion | 5.50% | 0.11x | $381.04 Million |
| LIFETECH SCI.DL-00000125 (81X) | $2.53 Billion | 11.56% | 0.26x | $893.41 Million |
| ORTOMA AB B (82Y) | $142.72 Million | -13.45% | 0.13x | $26.39 Million |
| COPLAND ROAD CAPITAL NEW (A2P) | $223.54 Million | 46.04% | 1.19x | $594.67 Million |
About MICROPORT CARDIO.MEDTECH.
MicroPort CardioFlow Medtech Corporation, a medical device company, engages in the research, development, and commercialization of transcatheter and surgical solutions for structural heart diseases in the People's Republic of China and internationally. The company engages in research and development, manufacture, and sale of medical devices in the field of left atrial appendage, and treating valv… Read more